Improving Long-Term Patient Outcomes in Age-Related Macular Degeneration

CME courses

  • Virtual Roundtable Improving Long-Term Patient Outcomes in Age-Related Macular Degeneration

    Faculty:  W. Lloyd Clark, M.D.; Jeffrey Heier, M.D.; William W. Li, M.D.; Quan Dong Nguyen, M.D., M.Sc.; John S. Pollack, M.D.; Charles C. Wykoff, M.D., Ph.D.

    The Angiogenesis Foundation convened an expert virtual roundtable on optimizing clinical utilization and long-term treatment outcomes in AMD. The panel of experts shared their perspectives on and recommendations for long-term treatment outcomes in age-related macular degeneration. The program materials consist of an audio recording of the virtual roundtable, infographics illustrating the major points of the discussion, and a white paper report.

     

    Credits

    0.50

    AMA PRA Category

    1 Credits™

  • Virtual Roundtable Using Effective Health Policy to Optimize Long-Term Patient Outcomes for Wet AMD: An Expert Roundtable and Article

    Faculty:  Roger A. Goldberg, M.D., M.B.A.; William T. Koch, COA, COE, CPC; William W. Li, M.D.; Nancey K. McCann

    The Angiogenesis Foundation convened an expert roundtable on using effective health policy to optimize long-term AMD outcomes with anti-VEGF treatment. The Foundation invited healthcare policy influencers, administrators, and retina experts to share their perspectives on current and imminent issues surrounding policy and regulatory change, their implications on anti-VEGF treatment for wet AMD, and their recommendations for strategies to optimize long-term treatment outcomes.

     

    Credits

    1.0

    AMA PRA Category

    1 Credits™